|
|
Volumn 3, Issue 5, 2010, Pages 431-437
|
|
Cardiovascular drug discovery in the academic setting: Building infrastructure, harnessing strengths, and seeking synergies
a
|
|
Author keywords
Cardiovascular Disease; Drug Discovery; Sanford Burnham Medical Research Institute; Therapeutic Target; Translational Research
|
|
Indexed keywords
BIOLOGICAL MARKER;
CARDIOVASCULAR AGENT;
CARDIOVASCULAR DISEASE;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG TARGETING;
GOVERNMENT REGULATION;
HUMAN;
MEDICAL RESEARCH;
METABOLOMICS;
MOLECULARLY TARGETED THERAPY;
MOTIVATION;
NON PROFIT ORGANIZATION;
NONHUMAN;
PRIORITY JOURNAL;
REVIEW;
TREND STUDY;
VALIDATION PROCESS;
ACADEMIES AND INSTITUTES;
ANIMALS;
CARDIOVASCULAR AGENTS;
CARDIOVASCULAR DISEASES;
COOPERATIVE BEHAVIOR;
DIFFUSION OF INNOVATION;
DRUG DISCOVERY;
DRUG INDUSTRY;
HUMANS;
INTERINSTITUTIONAL RELATIONS;
MOLECULAR TARGETED THERAPY;
ORGANIZATIONAL OBJECTIVES;
ORGANIZATIONS, NONPROFIT;
PROGRAM DEVELOPMENT;
TRANSLATIONAL RESEARCH;
|
|
EID: 77958107564
PISSN: 19375387
EISSN: 19375395
Source Type: Journal
DOI: 10.1007/s12265-010-9204-8 Document Type: Review |
|
Times cited : (2)
|
|
References (5)
|
